Synthesis and evaluation of the effects of solid lipid nanoparticles of ivermectin and ivermectin on cuprizone-induced demyelination in male C57BL/6 mice (2023)

Peer-Reviewed Study · Noori T, Dehpour AR, Alavi SD, Hosseini SZ, et al. · November 2023

Noori T et al., 2023-11: Iranian mouse study in the cuprizone demyelination model finding both ivermectin and ivermectin-loaded nanoparticles reduced demyelination and improved behavioural measures.

The results evidenced that IVM and nano-IVM administration is capable of reducing demyelination in mice.

Noori T et al., 2023-11: Iranian mouse study in the cuprizone demyelination model finding both ivermectin and ivermectin-loaded nanoparticles reduced demyelination and improved behavioural measures. Animal study, four groups of 7 male C57BL/6 mice (control, cuprizone, ivermectin, nano-ivermectin), Iran; demyelination induced with 0.2% cuprizone for 6 weeks; ivermectin and nano-ivermectin 1 mg/kg/day intraperitoneally for the last 14 days. Comparator: cuprizone-only and normal-diet controls. Declared conflicts: none. Evidence level: animal model, small groups (n=7), intraperitoneal route not used in humans. Study type: animal.